Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Convertible Debt (2016 - 2018)

Historic Convertible Debt for Jaguar Health (JAGX) over the last 4 years, with Q3 2018 value amounting to $10.7 million.

  • Jaguar Health's Convertible Debt fell 447.97% to $10.7 million in Q3 2018 from the same period last year, while for Sep 2018 it was $10.7 million, marking a year-over-year decrease of 447.97%. This contributed to the annual value of $11.0 million for FY2017, which is 722162.47% up from last year.
  • Per Jaguar Health's latest filing, its Convertible Debt stood at $10.7 million for Q3 2018, which was down 447.97% from $11.0 million recorded in Q4 2017.
  • In the past 5 years, Jaguar Health's Convertible Debt registered a high of $11.2 million during Q3 2017, and its lowest value of -$100000.0 during Q4 2015.
  • For the 4-year period, Jaguar Health's Convertible Debt averaged around $6.6 million, with its median value being $10.7 million (2018).
  • In the last 5 years, Jaguar Health's Convertible Debt skyrocketed by 722162.47% in 2017 and then plummeted by 447.97% in 2018.
  • Jaguar Health's Convertible Debt (Quarter) stood at -$100000.0 in 2015, then surged by 250.0% to $150000.0 in 2016, then soared by 7221.62% to $11.0 million in 2017, then dropped by 2.93% to $10.7 million in 2018.
  • Its last three reported values are $10.7 million in Q3 2018, $11.0 million for Q4 2017, and $11.2 million during Q3 2017.